n-benzyloxycarbonylprolylprolinal has been researched along with n-(n-(phenyl)butyryl-l-prolyl)pyrrolidine in 5 studies
| Studies (n-benzyloxycarbonylprolylprolinal) | Trials (n-benzyloxycarbonylprolylprolinal) | Recent Studies (post-2010) (n-benzyloxycarbonylprolylprolinal) | Studies (n-(n-(phenyl)butyryl-l-prolyl)pyrrolidine) | Trials (n-(n-(phenyl)butyryl-l-prolyl)pyrrolidine) | Recent Studies (post-2010) (n-(n-(phenyl)butyryl-l-prolyl)pyrrolidine) |
|---|---|---|---|---|---|
| 39 | 0 | 7 | 17 | 0 | 3 |
| Protein | Taxonomy | n-benzyloxycarbonylprolylprolinal (IC50) | n-(n-(phenyl)butyryl-l-prolyl)pyrrolidine (IC50) |
|---|---|---|---|
| Prolyl endopeptidase | Rattus norvegicus (Norway rat) | 0.0072 | |
| Metabotropic glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.13 | |
| Prolyl endopeptidase | Sus scrofa (pig) | 0.0297 | |
| Prolyl endopeptidase | Homo sapiens (human) | 0.0847 | |
| Prolyl endopeptidase | Mus musculus (house mouse) | 0.0047 | |
| Prolyl endopeptidase | Bos taurus (cattle) | 2.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, H; Ikeda, Y; Kobayashi, N; Nishioka, H; Niwa, S; Tanaka, Y; Torizuka, M; Yamanaka, T; Yoshinaga, K | 1 |
| Benoist, A; De Nanteuil, G; Hervé, Y; Lepagnol, J; Portevin, B; Rémond, G; Vincent, M | 1 |
| Christiaans, JA; Forsberg, MM; Gynther, J; Männistö, PT; Venäläinen, JI; Wallén, EA | 1 |
| Christiaans, JA; Forsberg, MM; Gynther, J; Jarho, EM; Männistö, PT; Poso, A; Venäläinen, JI; Wallén, EA | 1 |
| Gerber-Lemaire, S; Juillerat-Jeanneret, L; Lawandi, J; Moitessier, N | 1 |
1 review(s) available for n-benzyloxycarbonylprolylprolinal and n-(n-(phenyl)butyryl-l-prolyl)pyrrolidine
| Article | Year |
|---|---|
Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.
Topics: Animals; Blood-Brain Barrier; Central Nervous System; Humans; Prolyl Oligopeptidases; Protein Binding; Serine Endopeptidases; Serine Proteinase Inhibitors | 2010 |
4 other study(ies) available for n-benzyloxycarbonylprolylprolinal and n-(n-(phenyl)butyryl-l-prolyl)pyrrolidine
| Article | Year |
|---|---|
New potent prolyl endopeptidase inhibitors: synthesis and structure-activity relationships of indan and tetralin derivatives and their analogues.
Topics: Animals; Brain; Dogs; In Vitro Techniques; Indans; Magnetic Resonance Spectroscopy; Proline; Prolyl Oligopeptidases; Pyrroles; Serine Endopeptidases; Serine Proteinase Inhibitors; Spectrophotometry, Infrared; Structure-Activity Relationship; Tetrahydronaphthalenes | 1994 |
New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives.
Topics: Alzheimer Disease; Amino Acid Sequence; Amnesia; Animals; Avoidance Learning; Bridged Bicyclo Compounds, Heterocyclic; Drug Design; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Sequence Data; Nerve Tissue Proteins; Prolyl Oligopeptidases; Pyrroles; Rats; Scopolamine; Serine Endopeptidases; Serine Proteinase Inhibitors; Structure-Activity Relationship | 1996 |
Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitors.
Topics: Amides; Animals; Brain; Proline; Prolyl Oligopeptidases; Pyrrolidines; Serine Endopeptidases; Serine Proteinase Inhibitors; Structure-Activity Relationship; Swine | 2002 |
Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions.
Topics: Amides; Animals; Aza Compounds; Brain; Dicarboxylic Acids; In Vitro Techniques; Models, Molecular; Proline; Prolyl Oligopeptidases; Pyrrolidines; Quantitative Structure-Activity Relationship; Serine Endopeptidases; Serine Proteinase Inhibitors; Swine | 2005 |